ADAM9 and neoplasm: Significant correlation was observed between upregulation of ADAM9 mRNA and poor RFS in patients with grade III tumor (Figure 3E, p < 0.01), while no significant correlation was found in patients with grade I and II tumors (Figure 3F, p = 0.21 and Figure 3G, p = 0.2).